argenx SE | Results Presentation Deck | 14 slides

argenx · 2023-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON

Slide inventory

14
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
The slide uses a circular process flow diagram to illustrate the company's growth strategy.summarize
Open slide detailBeat · Key Takeaways
04
summarize
Open slide detailBeat · Key Takeaways
05
The slide uses a timeline-based clinical trial design framework.present_framework
06
The slide outlines a randomized clinical trial structure.present_framework
07
The slide uses a list format to communicate a roadmap of clinical milestones.plan_implementation
Open slide detailBeat · RoadmapLoop · Maturity Curve
08
summarize
Open slide detailBeat · RoadmapLoop · Maturity Curve
09
The slide uses a 2D matrix-like structure to show expansion vectors.plan_implementation
Open slide detailBeat · RoadmapLoop · Maturity Curve
10
The slide uses a central circular image overlaying a four-quadrant layout of strategic pillars.summarize
Open slide detailBeat · Key TakeawaysLoop · Quick Win Big Bet
11
The slide uses a chronological progression (Today vs Future) to outline product development milestones.plan_implementation
12
The map uses teal dots for VYVGART and a purple dot for VYVGART Hytrulo, though the legend is implicit in the side tables.establish_context
13
The slide combines corporate messaging with a personal patient story to humanize the clinical data.illustrate_case
14
The slide uses a hub-and-spoke visual metaphor to represent corporate values.summarize